Until the advent of CFTR modulators, treatment was limited to the sequelae of CF with a focus on improving nutritional status with enzyme replacement, airway clearance with mucolytics, and treating recurrent respiratory infections [14]. This evidence concerns the gene CFTR and cystic fibrosis.